Thai PBS Thai PBS
Pfizer/BioNTech seek Covid jab approval for 12-15-year-olds in EU

Pfizer/BioNTech seek Covid jab approval for 12-15-year-olds in EU

13 Sept 06:48 Key points summarised by AI
  • Pfizer/BioNTech have formally requested European regulators to authorize their COVID-19 vaccine for 12- to 15-year-olds, a crucial step towards achieving herd immunity.
  • This move follows a similar request made to US authorities earlier this month, with the vaccine currently approved only for individuals aged 16 and over.
  • Phase 3 trial data demonstrated the vaccine's 100% effectiveness and robust antibody responses in the 12-15 age group, with good tolerability.
  • If approved, the vaccine could be available for this age group from June, with trials for younger children (5-12 and six months upwards) also underway, showing encouraging results.
Read full article
World 1/2
Skip > Skip >